{{Rsnum
|rsid=7571971
|Gene=EIF2AK3
|Chromosome=2
|position=88595833
|Orientation=plus
|GMAF=0.2874
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=EIF2AK3
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 48.6 | 42.1 | 9.3
| HCB | 22.0 | 55.3 | 22.7
| JPT | 35.5 | 44.5 | 20.0
| YRI | 100.0 | 0.0 | 0.0
| ASW | 90.9 | 9.1 | 0.0
| CHB | 22.0 | 55.3 | 22.7
| CHD | 29.8 | 44.2 | 26.0
| GIH | 42.0 | 41.0 | 17.0
| LWK | 91.5 | 8.5 | 0.0
| MEX | 38.6 | 50.9 | 10.5
| MKK | 74.3 | 25.0 | 0.7
| TSI | 55.9 | 37.3 | 6.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21685912
|Trait=None
|Title=Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.
|RiskAllele=
|Pval=4E-13
|OR=1.3300
|ORtxt=[1.22-1.43]
|OA=1
}}

{{PMID Auto
|PMID=23116876
|Title=An exploratory study on STX6, MOBP, MAPT, and EIF2AK3 and late-onset Alzheimer's disease.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}